-
-
-
-
NMI project WOUNDSENS - 23/10/2024
Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.
https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres
-
-
Sustainable medical technology - 10/10/2024
Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.
https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology
-
-
-
-
-
-
-
-
-
-
Press release - 19/09/2024
Personalized medicine with individually tailored therapies is becoming more a reality in cancer. This requires a look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out in Germany. The data is a prerequisite for integrating gene sequencing into routine care.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-standards-looking-tumor-genome
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Pipetting robot for academic research - 28/08/2024
Repetitive tasks that researchers have to conduct in the lab tend to be tiring and often lead to errors. Precise pipetting is crucial for achieving reproducible results. Automation is underrepresented in research labs and existing pipetting robots are unsuitable for scientists. This is why Dr. Julius Wiener, Tobias Zundel and Oliver Brunner decided to found the company goodBot GmbH and develop a pipetting robot tailored to academic research.
https://www.gesundheitsindustrie-bw.de/en/article/news/goodbot-gmbh-third-arm-researchers
-
-
Press release - 22/08/2024
Knowledge of the target structures for the immune cells is a basic prerequisite for the development of personalized cancer immunotherapies. Scientists from the German Cancer Research Center and the NCT Heidelberg are publishing a sensitive method based on mass spectroscopy to identify such tumor-specific "neoepitopes". The analytical method is designed to detect these low abundance protein fragments and requires minimal amounts of…
https://www.gesundheitsindustrie-bw.de/en/article/press-release/validated-targets-personalized-cancer-immunotherapy
-
-
-
-
-
-
Press release - 13/08/2024
A cutting-edge chemical process is the first to make it possible to quickly and easily produce modified peptides with boronic acids. As part of this work, scientists managed to synthesize a large number of different biologically active peptide boronic acids and investigate their properties. They open up new possibilities in the young research field of synthetic immunology and could go on to be used primarily in immunotherapy.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/peptide-boronic-acids-new-prospects-immunology
-
Start-up Cerebri GmbH - 05/08/2024
Fewer and fewer patients are getting timely access to electroencephalograms, as the process of measuring brain activity and interpreting the results requires specific expertise. Cerebri GmbH, a newly established Tübingen-based company, aims to address this issue by offering user-friendly EEG caps and providing rapid, location-independent and top-tier diagnostics by experts.
https://www.gesundheitsindustrie-bw.de/en/article/news/comprehensive-eeg-supply-thanks-telemedicine
-
Press release - 01/08/2024
Encouraging results from a large international study led by Heidelberg have recently been published in the journal “Lancet”: The genetic material of cancer cells with unknown tissue of origin contains numerous targets for specific drugs that are already available and have been developed to treat other forms of cancer. These suppressed the disease in CUP patients for significantly longer than chemotherapy.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/targeted-therapy-cancer-unknown-primary-cup
-
-
The start of a transnational cooperation for a future of sustainable healthcare - 25/07/2024
The HACK-IT-NET (“Health And Care Knowledge and Innovation Transfer NETwork”) project aims to provide holistic and seamless healthcare for all patients in the Alpine region. The project, which was launched in July 2024 and will run for three years, aims to bring together stakeholders in the healthcare sector to create a forward-looking healthcare ecosystem in the Alpine region. BIOPRO is a partner.
https://www.bio-pro.de/en/information/press-release/biopro-sustainability-partner-eu-hack-it-net-project
-
-
-
Research association - 24/07/2024
Every person is unique – even when they are ill. This is why many approaches to personalised medicine have been under development. The Stuttgart Partnership Initiative - Mass Personalization (SPI-MP), which focuses on basic research into fabrication and biomaterial technologies for personalised biomedical systems, is at the heart of such research work. The projects range from artificial knee joint cartilage to state-of-the-art stroke diagnostics.
https://www.gesundheitsindustrie-bw.de/en/article/news/spi-mp-pioneer-personalised-medical-technology
-
-
-
-
-
-
-
-
-
-
-
Press release - 05/07/2024
With "OrgaPlexing", scientists at the MPI of Immunobiology and Epigenetics have developed a new method that shows how guardian cells of the immune system, the macrophages, orchestrate their cell structures during inflammation or bacterial infection, making it possible to observe the interactions between several organelles simultaneously and thus providing insights into cell metabolism and the production of inflammatory molecules.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/symphony-organelles
-
-
-
-
-
-
-
-
-
-
-
Baden-Württemberg receives the EU Commission's "Regional Innovation Valley" label - 01/07/2024
The EU research project PRECISEU, which started in June 2024 and will run for five years, aims to connect innovation ecosystems across Europe and advance personalised medicine throughout Europe. BIOPRO Baden-Württemberg is one of 25 partner organisations from 11 European countries that are working on the further development of customised healthcare as part of the research project.
https://www.bio-pro.de/en/information/press-release/customised-healthcare-all-biopro-partner-eu-project-preciseu
-
Press release - 24/06/2024
Researchers at University of Galway, the Heidelberg Institute for Theoretical Studies (HITS) Heidelberg University, and Heidelberg University Hospital have created digital babies to better understand infants’ health in their critical first 180 days of life. The international team created computer models that simulate the unique metabolic processes of each baby. The models can help to better understand rare metabolic diseases.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/digital-babies-created-improve-infant-healthcare
-
-
-
-
Gender-specific differences - 18/06/2024
Gender medicine is the study of gender-specific health differences. Many diseases manifest themselves differently in men and women and therapies do not always have the same effect depending on the sex of the patient being treated. There is currently not enough data on these differences. Research teams including the one led by Professor Dr. Dr. Sonja Loges from the University Medical Centre Mannheim and the DKFZ are seeking to change this.
https://www.gesundheitsindustrie-bw.de/en/article/news/gender-medicine-why-good-healthcare-not-matter-course-everyone
-
-
-
Website address: https://www.biooekonomie-bw.de/en/search